SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Drugdoctor, dr_lowenstein, lasers, NASDAQ2020, IB_, Chasing
Search This Board: 
Last Post: 9/20/2017 11:47:05 PM - Followers: 833 - Board type: Free - Posts Today: 0

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 09/07/2017 04:32:57 PM
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
ELTP News: Quarterly Report (10-q) 08/09/2017 04:30:20 PM
ELTP News: Current Report Filing (8-k) 07/28/2017 12:59:52 PM
ELTP News: Confidential Treatment Order (ct Order) 07/12/2017 05:00:02 PM
PostSubject
#271297  Sticky Note Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release SCHH 09/20/17 08:41:36 AM
#271038  Sticky Note Elite Pharma at Pain Week 2017 NASDAQ2020 09/17/17 04:03:01 PM
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Admin [Dan] 02/23/16 09:32:46 PM
#271533   yes, but do not forget that since that dr_lowenstein 09/20/17 11:47:05 PM
#271532   Very good post WeeZuhl. julesnemo3 09/20/17 11:11:07 PM
#271531   Outstanding..another ANDA for ELTP. They just keep julesnemo3 09/20/17 11:09:23 PM
#271530   Excellent post. Tremendous insight. BS Sifter 09/20/17 10:51:14 PM
#271528   Gee please list all the other pharma companies Couch 09/20/17 09:52:28 PM
#271527   One more AD generic ER Oxycodone and the NASDAQ2020 09/20/17 09:50:44 PM
#271526   Surely 10¢ OTC Elite will be, can be, John_Langston 09/20/17 09:03:17 PM
#271524   If I had held for all those years John_Langston 09/20/17 08:37:18 PM
#271522   Facts will take ELTP to sub-penny, we need John_Langston 09/20/17 08:25:15 PM
#271521   NasRAT said "The Patel brothers, who is that" lol John_Langston 09/20/17 08:22:47 PM
#271520   So elite has one attorney that no one John_Langston 09/20/17 08:20:36 PM
#271519   Real impressive I got a few stocks that stockboy 09/20/17 08:18:03 PM
#271518   4. Epic does NOT market a generic of WeeZuhl 09/20/17 08:16:04 PM
#271517   Elite sounds real "worried" John_Langston 09/20/17 08:13:07 PM
#271515   Why when so many stock are rocking John_Langston 09/20/17 08:07:31 PM
#271514   You still believe in this scam? After 2 stockboy 09/20/17 08:02:46 PM
#271513   Now that VNDM has showed themselves on the John_Langston 09/20/17 08:02:07 PM
#271512   LMAO; and here I bought at .06 and Couch 09/20/17 07:44:09 PM
#271511   I have been hearing that that since ELTP John_Langston 09/20/17 07:39:31 PM
#271510   I understand the Elite board John_Langston 09/20/17 07:36:52 PM
#271509   I understand, someone said something about a happy John_Langston 09/20/17 07:31:02 PM
#271508   "SOON" = another 20 plus years for the Couch 09/20/17 07:23:47 PM
#271507   "SOON" = another 20 plus years for the John_Langston 09/20/17 07:18:41 PM
#271506   "SOON" = another 20 plus years for the Couch 09/20/17 07:16:02 PM
#271505   From 35¢ to 10¢ = WHOOPSY!!! It was John_Langston 09/20/17 07:14:04 PM
#271504   Now that VNDM has showed themselves on the offer John_Langston 09/20/17 07:12:33 PM
#271503   Clearly not on pharma shelves. Couch 09/20/17 07:08:10 PM
#271502   LMFAO - boiler plate pharm 101. Couch 09/20/17 06:58:29 PM
#271501   Gee sure k - must be why the Couch 09/20/17 06:54:17 PM
#271500   LMFAO - and here I bought at .06 Couch 09/20/17 06:52:23 PM
#271499   At this point no one cares anymore and John_Langston 09/20/17 06:41:58 PM
#271498   Clearly not on pharma shelves. Was supposed to jour_trader 09/20/17 06:39:02 PM
#271497   Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended John_Langston 09/20/17 06:38:59 PM
#271496   ..."we do not anticipate generic manufacturers selling the jour_trader 09/20/17 06:31:21 PM
#271495   Who knows; it's like nothing I have ever John_Langston 09/20/17 06:30:24 PM
#271494   Maybe because NasRAT pays them in free shares stockboy 09/20/17 06:28:13 PM
#271493   Never underestimate the power of the MMs!!! They John_Langston 09/20/17 06:27:12 PM
#271492   Thanks John for pointing out the facts yet stockboy 09/20/17 06:23:56 PM
#271491   if one looks closely at the Epic label dr_lowenstein 09/20/17 06:23:33 PM
#271490   any time you mention OXYCONTIN in and ANDA, John_Langston 09/20/17 06:20:10 PM
#271489   Just whisper something to Donald and deportation proceedings stockboy 09/20/17 06:18:13 PM
#271488   Don't blame that one on me later. John_Langston 09/20/17 06:16:53 PM
#271487   Too bad this was the only PR for stockboy 09/20/17 06:14:12 PM
#271486   THANK YOU John_Langston I GOT MY ORDER FILLED doczugunda 09/20/17 06:10:56 PM
#271484   Insiders hoarding massive amounts of shares and John_Langston 09/20/17 06:06:36 PM
#271483   the suckers are the ones not buying and John_Langston 09/20/17 06:03:50 PM
#271482   the perfect time John_Langston 09/20/17 06:01:41 PM
#271481   TIME for the REAL FACTS!!! Couch 09/20/17 05:51:39 PM
#271480   Time for FACTS dr_lowenstein 09/20/17 05:45:08 PM
#271479   Congratulations on dumping Elite at the perfect time namtae 09/20/17 05:41:38 PM
PostSubject